Trial Profile

Imiquimod/BTIC Lysate-Based Vaccine Immunotherapy for Diffuse Intrinsic Pontine Glioma in Children and Young Adults

Status: Discontinued

Phase of Trial: Phase I

Latest Information Update: 20 Mar 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Imiquimod (Primary) ; Brain cancer vaccine
Indications Diffuse intrinsic pontine glioma; Glioblastoma; Glioma
Focus Adverse reactions

Most Recent Events

16 Mar 2020 Status changed from suspended to discontinued.
11 Nov 2019 Planned End Date changed from 10 Oct 2019 to 10 Feb 2020.
12 Feb 2019 Planned End Date changed from 1 Aug 2017 to 10 Oct 2019.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com